Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Match Group Inc (MTCH) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Match Group IncTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Match Group Inc vs Recursion Pharmaceuticals Inc — how do they compare? Match Group Inc trades at $39.02 (market cap $9.10B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Match Group Inc is far larger — about 5.9× Recursion Pharmaceuticals Inc's market cap, and Match Group Inc pays a 2.05% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

MTCHRXRX
Market Cap
$9.10B$1.53B
Sector
MediaHealth
52-Week High
$40.29$6.79
52-Week Low
$28.90$2.84
Enterprise Value
$12.05B$946.50M
Dividend Yield
2.05%

Returns comparison

Trailing returns across standard periods

About Match Group Inc

Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).

Read more on MTCH

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX